At the news
? NEUTRALIMPACT 2/10 DEFA14A filed Apr 7, 2026 at 08:16 ET
Thermo Fisher Scientific Inc. filed a definitive proxy statement for its 2026 annual meeting, which is a routine regulatory filing. The document outlines standard corporate governance matters such as director elections and executive compensation, with no material financial or strategic changes disclosed.
- Company filed a definitive proxy statement (DEFA14A) for its 2026 annual meeting
- Filing is routine and does not contain material financial or strategic changes
- Document is standard corporate governance disclosure
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access